H.R. 1620 · 119th Congress · House

Finn Sawyer Access to Cancer Testing Act

Active· Introduced in House
Introduced
Feb 26, 25
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Finn Sawyer Access to Cancer Testing Act

This bill provides for coverage of certain cancer diagnostic and laboratory tests under Medicare, Medicaid, and the Children's Health Insurance Program (CHIP). Specifically, the bill provides for coverage of microarray analysis, DNA and RNA sequencing, whole-exome sequencing, and other next-generation sequencing for individuals diagnosed with cancer.

Additionally, the Department of Health and Human Services must establish an education and awareness program for physicians and the public about genomic testing and the role of genetic counselors.

Action Timeline

2
  1. FEB 26, 2025House floor actions

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  2. FEB 26, 2025Library of Congress

    Introduced in House

Committees

2

Ways and Means Committee

hswm00

Referred: Feb 26, 2025

Active

Energy and Commerce Committee

hsif00

Referred: Feb 26, 2025

Active